ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,487.03
0.25%
US Tech 100
19,430.40
0.14%
다우존스 지수
38,834.86
0.15%
Bitcoin
64,800.00
-0.52%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU
  6. PHAXIAM Therapeutics SA (PHXM)

  7. PHAXIAM Therapeutics SA (PHXM) 뉴스

PHXM

PHAXIAM Therapeutics (PHXM)

PHAXIAM Therapeutics SA
일자:
정렬 기준:
 검색 관련기사 보기:EU:PHXM
일자시간출처헤드라인심볼기업
2024/06/1215:00GlobeNewswire Inc.Lancement d'une augmentation de capital avec maintien du DPS d’un montant d’environ 10 M€, susceptible d’être porté à environ 11,5 M€ en cas d’exercice intégral de la clause d'extensionEU:PHXMPHAXIAM Therapeutics SA
2024/06/0800:45GlobeNewswire Inc.PHAXIAM annonce les modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 28 juin 2024EU:PHXMPHAXIAM Therapeutics SA
2024/06/0800:45GlobeNewswire Inc.PHAXIAM announces the availability of the preparatory documents for the Combined General Meeting of 28 June 2024EU:PHXMPHAXIAM Therapeutics SA
2024/06/0601:00GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2024EU:PHXMPHAXIAM Therapeutics SA
2024/06/0601:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – May 31, 2024EU:PHXMPHAXIAM Therapeutics SA
2024/05/1600:45GlobeNewswire Inc.PHAXIAM Therapeutics fait le point sur ses activités et publie l’information financière du premier trimestre 2024EU:PHXMPHAXIAM Therapeutics SA
2024/05/1600:45GlobeNewswire Inc.PHAXIAM provides Business and Financial Update for the First Quarter of 2024EU:PHXMPHAXIAM Therapeutics SA
2024/05/0401:05GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2024EU:PHXMPHAXIAM Therapeutics SA
2024/05/0401:05GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2024EU:PHXMPHAXIAM Therapeutics SA
2024/04/1514:30GlobeNewswire Inc.PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureusEU:PHXMPHAXIAM Therapeutics SA
2024/04/1514:30GlobeNewswire Inc.PHAXIAM Therapeutics annonce le recrutement du premier patient dans l’étude de phase 1 dans l’endocardite infectieuse causée par le Staphylococcus aureusEU:PHXMPHAXIAM Therapeutics SA
2024/04/1001:00GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 mars 2024EU:PHXMPHAXIAM Therapeutics SA
2024/04/1001:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – March 29, 2024EU:PHXMPHAXIAM Therapeutics SA
2024/04/0601:00GlobeNewswire Inc.PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)EU:PHXMPHAXIAM Therapeutics SA
2024/04/0601:00GlobeNewswire Inc.PHAXIAM Therapeutics annonce le dépôt de son Document d’Enregistrement Universel (URD) 2023EU:PHXMPHAXIAM Therapeutics SA
2024/03/1115:00GlobeNewswire Inc.PHAXIAM Therapeutics annonce la réalisation du retrait volontaire de ses « American Depository Shares » du Nasdaq Stock MarketEU:PHXMPHAXIAM Therapeutics SA
2024/03/1115:00GlobeNewswire Inc.PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock MarketEU:PHXMPHAXIAM Therapeutics SA
2024/03/1115:00GlobeNewswire Inc.PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock MarketEU:PHXMPHAXIAM Therapeutics SA
2024/03/0602:00GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 février 2024EU:PHXMPHAXIAM Therapeutics SA
2024/03/0602:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - February 29, 2024EU:PHXMPHAXIAM Therapeutics SA
2024/02/2106:05GlobeNewswire Inc.PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketEU:PHXMPHAXIAM Therapeutics SA
2024/02/2106:05GlobeNewswire Inc.PHAXIAM Therapeutics annonce son intention de procéder au retrait volontaire de ses « American Depositary Shares » du Nasdaq Capital MarketEU:PHXMPHAXIAM Therapeutics SA
2024/02/2106:05GlobeNewswire Inc.PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketEU:PHXMPHAXIAM Therapeutics SA
2024/02/0706:05GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - January 31, 2024EU:PHXMPHAXIAM Therapeutics SA
2024/02/0706:05GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2024EU:PHXMPHAXIAM Therapeutics SA
2024/01/1906:05GlobeNewswire Inc.PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024EU:PHXMPHAXIAM Therapeutics SA
2024/01/1906:05GlobeNewswire Inc.PHAXIAM Therapeutics annonce son niveau de trésorerie à fin 2023 et son calendrier financier 2024EU:PHXMPHAXIAM Therapeutics SA
2024/01/1906:05GlobeNewswire Inc.PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024EU:PHXMPHAXIAM Therapeutics SA
2024/01/0406:05GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2023EU:PHXMPHAXIAM Therapeutics SA
2024/01/0406:05GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - December 31, 2023EU:PHXMPHAXIAM Therapeutics SA
 검색 관련기사 보기:EU:PHXM

최근 히스토리

BIT
P10A10
Bnp Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유